pleural
effus
common
medic
problem
chest
involv
accumul
abnorm
amount
pleural
fluid
pleural
space
sever
diseas
congest
heart
failur
liver
cirrhosi
tuberculosi
adenocarcinoma
pneumonia
common
diseas
caus
pleural
effus
rapid
accur
diagnost
method
pleural
effus
convent
diagnosi
tubercul
pleurisi
base
pleural
fluid
cytolog
cultur
pleural
effus
pleural
biopsi
tissu
cultur
method
low
sensit
recognis
limit
clinic
use
usual
requir
week
posit
cultur
report
therefor
reliabl
clinic
marker
provid
simpl
rapid
accur
diagnosi
requir
patient
pleural
effus
circul
reninangiotensin
system
ra
play
welldescrib
role
maintain
blood
pressur
homeostasi
recent
local
tissuebas
ra
also
describ
appear
play
key
role
injuryrepair
respons
express
ra
compon
elev
angiotensin
convert
enzym
ace
number
lung
diseas
suggest
exist
pulmonari
ra
angiotensin
ii
ang
ii
could
mediat
least
part
respons
lung
injuri
central
role
ace
gener
ang
ii
ang
ang
ii
key
effector
peptid
ra
caus
vasoconstrict
exert
multipl
biolog
function
ang
ii
also
caus
develop
interstiti
fibrosi
via
physiolog
regul
matrix
metalloproteinas
mmp
express
andor
activ
close
homologu
ace
function
neg
regul
angiotensin
system
identifi
key
receptor
sever
acut
respiratori
syndrom
coronaviru
infect
reduc
gener
ang
ii
catalys
convers
ang
facilit
hydrolysi
ang
ii
recognis
potenti
endogen
inhibitor
classic
ra
cascad
henc
axi
may
import
neg
modul
ang
ii
bioactiv
counteract
effect
ace
determin
net
tissu
ang
ii
level
abnorm
elev
ace
combin
decreas
express
may
involv
fibrot
process
vitro
vivo
mechan
may
involv
express
activ
specif
mmp
recent
abnorm
pleural
mmp
level
eg
report
associ
mmp
develop
pleurisi
investig
evalu
associ
two
key
enzym
ra
ace
pleural
fluid
patient
pleural
effus
also
detail
discuss
whether
abnorm
ra
accompani
high
level
might
caus
elev
activ
tubercul
pleural
effus
final
high
ratio
ace
combin
elev
detect
pleural
fluid
may
potenti
indic
diagnosi
tubercul
pleurisi
pleural
effus
patient
process
laboratori
august
decemb
pleural
effus
design
transud
exud
accord
light
criteria
definit
diagnosi
tubercul
pneumonia
adenocarcinoma
effus
exud
verifi
examin
effus
biochemistri
cytolog
acidfast
stain
clinic
followup
studi
perform
approv
institut
review
board
mackay
memori
hospit
inform
consent
obtain
patient
accord
light
criteria
pleural
effus
divid
transud
pleural
effus
exud
pleural
effus
exud
pleural
effus
divid
tubercul
pleural
effus
patient
pneumonia
pleural
effus
patient
malign
pleural
effus
patient
fresh
pleural
fluid
collect
steril
tube
without
anticoagul
reagent
prevent
releas
gelatinas
platelet
activ
tube
immedi
centrifug
g
minut
separ
supernat
cell
pellet
supernat
aliquot
store
cell
pellet
use
pleural
effus
sampl
routin
pleural
analys
includ
total
protein
lactat
dehydrogenas
ldh
glucos
white
blood
cell
wbc
count
addit
activ
ace
gelatinas
pleural
effus
measur
gelatin
zymographi
detect
activ
perform
gelatincontain
gel
previou
report
briefli
pleural
fluid
subject
load
sdspage
contain
gelatin
sigmaaldrich
st
loui
mo
usa
gelatinas
activ
identifi
clear
zone
blue
background
sdspage
quantifi
use
scion
imag
softwar
nih
bethesda
md
usa
quantifi
extent
lysi
band
contain
gelatinas
enzym
activ
express
ace
activ
assay
fluorogen
substrat
mcayvadapk
mcaapkdnp
anaspec
san
jose
ca
usa
respect
accord
wysocki
et
al
slight
modif
assay
perform
microquartz
cuvett
pleural
fluid
fluorogen
substrat
proteas
inhibitor
cocktail
sigmaaldrich
final
volum
ace
assay
buffer
reaction
follow
kinet
hour
use
fluoresc
reader
excit
wavelength
nm
emiss
wavelength
nm
data
fit
plot
use
grafit
sigmaaldrich
enzym
activ
express
parallel
sampl
incub
abovement
reaction
mixtur
presenc
captopril
sigmaaldrich
specif
ace
inhibitor
determin
specif
ace
activ
anaspec
specif
inhibitor
determin
specif
activ
level
variou
marker
pleural
effus
sampl
express
mean
standard
deviat
sd
shown
median
interquartil
rang
group
comparison
made
use
nonparametr
kruskalw
test
differ
consid
statist
signific
p
statist
analysi
perform
use
statist
softwar
spss
chicago
il
usa
pleural
fluid
characterist
patient
includ
studi
present
tabl
gener
total
protein
ldh
number
wbc
exud
effus
n
significantli
higher
transud
effus
n
p
wherea
lower
glucos
level
detect
pleural
fluid
exud
compar
transud
p
ace
activ
pleural
effus
patient
determin
ace
activ
exud
effus
higher
transud
effus
median
iqr
vs
p
figur
contrari
activ
exud
effus
lower
transud
effus
vs
figur
differ
statist
signific
ratio
activ
pleural
effus
significantli
higher
exud
effus
transud
effus
vs
p
figur
transud
signific
posit
correl
found
ace
activ
p
figur
howev
ace
activ
correl
activ
exud
effus
p
figur
activ
pleural
effus
patient
determin
gelatin
zymographi
figur
activ
exud
effus
compar
transud
effus
vs
figur
howev
activ
exud
effus
significantli
higher
transud
effus
vs
p
figur
wbc
number
glucos
total
protein
ldh
concentr
exud
three
type
tubercul
pneumonia
adenocarcinoma
effus
determin
tabl
data
show
wbc
number
glucos
ldh
concentr
determin
among
three
exud
effus
insignificantli
differ
elev
ace
activ
elev
ratio
observ
exud
effus
differenti
ace
activ
exud
accord
differ
diseas
includ
tuberculosi
pneumonia
adenocarcinoma
ace
activ
tubercul
pleural
effus
significantli
higher
pneumonia
adenocarcinoma
effus
p
p
fold
respect
figur
contrast
activ
tubercul
effus
significantli
lower
pneumonia
adenocarcinoma
effus
p
p
fold
respect
figur
accord
chang
detect
ace
significantli
higher
differ
ratio
tubercul
effus
compar
ratio
pneumonia
adenocarcinoma
effus
also
observ
p
figur
pleural
ace
activ
among
transud
tuberculosi
pneumonia
adenocarcinoma
compar
ace
activ
transud
tubercul
pneumonia
adenocarcinoma
effus
rfuhourml
rfuhourml
respect
note
ace
activ
pneumonia
adenocarcinoma
effus
similar
activ
transud
effus
activ
exud
effus
patient
differ
diseas
assay
gelatin
zymographi
figur
tubercul
pleural
effus
activ
p
fold
p
higher
activ
pneumonia
adenocarcinoma
effus
respect
figur
similar
activ
tubercul
effus
significantli
higher
activ
pneumonia
adenocarcinoma
effus
p
fold
p
respect
figur
present
studi
major
compon
ra
extracellular
matrix
ecm
metabol
pleural
ace
measur
patient
pleural
effus
main
find
significantli
higher
ace
activ
ratio
exud
effus
increas
ace
activ
combin
decreas
activ
tubercul
effus
compar
pneumonia
adenocarcinoma
effus
increas
activ
found
tubercul
effus
agreement
previou
report
herein
first
report
chang
ace
activ
associ
tubercul
pleurisi
report
publish
import
ace
pleural
fluid
ace
could
detect
pleural
fluid
ace
level
use
discrimin
cancer
noncanc
patient
et
al
also
measur
ace
pleural
effus
sera
patient
show
tubercul
effus
contain
higher
ace
concentr
type
nonrheumatoid
effus
result
indic
ace
determin
may
aid
differenti
rheumatoid
tubercul
pleurisi
type
pleural
diseas
present
studi
report
chang
activ
pleural
effus
physiolog
function
opposit
ace
signific
posit
correl
ace
activ
transud
suggest
ace
maintain
normal
physiolog
balanc
loss
balanc
exud
detect
increas
ace
although
import
dysregul
ace
exud
effus
explor
signific
role
ra
pathophysiolog
process
exud
develop
possibl
ace
activ
increas
p
decreas
p
tuberculosi
specif
ace
activ
differ
transud
pneumonia
adenocarcinoma
effus
result
indic
ace
mayb
biomark
tuberculosi
diagnosi
pleural
effus
could
emphas
increas
ace
activ
ratio
exud
mainli
contribut
higher
ace
level
lower
enzym
activ
tubercul
pleural
effus
advanc
assay
data
show
ace
activ
pleural
fluid
isol
tuberculosi
pneumonia
adenocarcinoma
transud
rfuhourml
respect
also
indic
increas
ace
activ
found
exud
mainli
contribut
higher
ace
activ
tubercul
pleural
effus
activ
tubercul
pneumonia
adenocarcinoma
effus
rfuhourml
mean
sd
respect
although
larger
sd
determin
pneumonia
adenocarcinoma
group
activ
group
significantli
larger
tuberculosi
group
p
advanc
assay
data
indic
tuberculosi
pneumonia
adenocarcinoma
patient
show
activ
rfuhourml
interquartil
rang
tubercul
effus
iqr
data
also
support
trend
decreas
activ
pleural
effus
tuberculosi
compar
pneumonia
adenocarcinoma
howev
patient
includ
order
examin
proposit
interest
significantli
increas
ace
activ
combin
markedli
decreas
activ
measur
tubercul
effus
result
confirm
abnorm
ra
metabol
pleural
space
may
relat
tubercul
pleurisi
report
overexpress
may
inhibit
activ
defici
lead
increas
level
inflammatori
signal
pathway
studi
ang
ii
could
stimul
human
monocyt
cell
increas
express
activ
significantli
via
activ
jnk
ace
inhibitor
captopril
administr
isoprenalineinduc
left
ventricular
fibrosi
rat
show
captopril
significantli
enhanc
isoprenalineinduc
myocardi
fibrosi
augment
isoprenalineinduc
express
addit
ang
regul
ra
oppos
ang
ii
effect
could
affect
express
overexpress
reduc
invas
abil
vitro
accord
downregul
ang
reveal
antimigr
antiinvas
effect
mediat
inactiv
jnk
signal
pathway
reduc
express
activ
accord
result
conclud
reduct
along
induct
activ
occur
observ
decreas
increas
activ
tubercul
effus
confirm
conclus
number
studi
indic
aceang
ii
axi
axi
regul
metabol
ecm
protein
also
modul
mmp
express
activ
level
mmp
implic
pathogenesi
variou
lung
diseas
includ
pleural
effus
activ
mmp
within
pleural
space
may
play
role
format
pleural
effus
alter
integr
mesotheli
endotheli
cell
layer
increas
vascular
permeabl
proteolysi
mmp
may
involv
format
pleural
effus
increas
vascular
permeabl
thu
facilit
fluid
influx
pleural
space
therefor
presenc
enzymat
activ
mmp
identifi
pleural
effus
previou
studi
shown
express
mmp
pleural
space
alter
varieti
inflammatori
malign
diseas
suggest
certain
member
mmp
famili
may
particip
format
pleural
effus
tissu
damag
characterist
manifest
mycobacterium
tuberculosi
infect
proteolysi
macrophagesecret
proteas
implic
destruct
process
regard
proteolyt
action
mmp
may
involv
pathogenesi
tuberculosi
like
mani
diseas
associ
tissu
destruct
sever
studi
report
macrophag
monocyt
releas
respons
tuberculosi
cellular
compon
studi
evalu
mmp
tubercul
pleural
effus
found
mmp
activ
pleural
fluid
higher
patient
tuberculosi
compar
patient
transud
effus
result
agreement
find
activ
highest
tubercul
effus
among
exud
examin
present
studi
first
report
ratio
tuberculosi
diagnosi
although
increas
ace
could
specif
determin
tubercul
effus
still
concern
address
use
ace
biomark
tuberculosi
diagnosi
elev
ace
level
may
also
seen
sever
cardiovascular
disord
inflammationinduc
target
sever
case
ra
axi
recent
highlight
counter
balanc
arm
ra
aceang
ii
axi
regulatori
mechan
focus
altern
ace
regul
still
lack
therefor
mechan
reduc
found
pleural
effus
patient
tuberculosi
remain
explor
data
suggest
interplay
ace
essenti
function
ra
chang
gelatinas
activ
may
involv
develop
pleural
effus
find
suggest
increas
ace
activ
decreas
activ
pleural
fluid
featur
pleural
space
infect
patient
pleural
tuberculosi
measur
may
help
diagnos
tubercul
pleurisi
howev
find
present
studi
requir
valid
larg
prospect
studi
examin
treatment
outcom
unselect
patient
tuberculosi
indic
becom
part
clinic
meaning
practic
